Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

An initiative to reduce insulin-related adverse drug events in a children's hospital.

Lawson SA, Hornung LN, Lawrence M, et al. An initiative to reduce insulin-related adverse drug events in a children's hospital. Pediatrics. 2022;149(1):e2020004937. doi:10.1542/peds.2020-004937.

Save
Print Download PDF
February 16, 2022
Lawson SA, Hornung LN, Lawrence M, et al. Pediatrics. 2022;149(1):e2020004937.
View more articles from the same authors.

Insulin is a high-risk medication and can contribute to adverse events in pediatric patients. This paper describes one children’s hospital’s experience implementing a new standardized medication administration process for insulin and the impact on insulin-related adverse drug events (ADEs). Findings indicate that implementation of a PRN (i.e., “as needed”) ordering process and clinician education decreased insulin-related ADEs and reduced the time between blood glucose checks and insulin administration.

Save
Print Download PDF
Cite
Citation

Lawson SA, Hornung LN, Lawrence M, et al. An initiative to reduce insulin-related adverse drug events in a children's hospital. Pediatrics. 2022;149(1):e2020004937. doi:10.1542/peds.2020-004937.

Related Resources From the Same Author(s)